<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Cephalalgia</journal-id><journal-id journal-id-type="publisher-id">CEP</journal-id><journal-id journal-id-type="hwp">spcep</journal-id><journal-title-group><journal-title>Cephalalgia </journal-title></journal-title-group><issn pub-type="ppub">0333-1024</issn><issn pub-type="epub">1468-2982</issn><publisher><publisher-name>SAGE Publications</publisher-name><publisher-loc>UK</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">20647174</article-id><article-id pub-id-type="pmc">2899772</article-id><article-id pub-id-type="doi">10.1177/0333102410361404</article-id><article-id pub-id-type="publisher-id">10.1177_0333102410361404</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Articles</subject></subj-group></article-categories><title-group><article-title>Diet restriction in migraine, based on IgG against foods: A clinical
                    double-blind, randomised, cross-over trial</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Alpay</surname><given-names>Kadriye</given-names></name><xref ref-type="aff" rid="aff1-0333102410361404">1</xref></contrib><contrib contrib-type="author"><name><surname>Erta&#x0015f;</surname><given-names>Mustafa</given-names></name><xref ref-type="aff" rid="aff1-0333102410361404">1</xref><xref ref-type="corresp" rid="corresp1-0333102410361404"/></contrib><contrib contrib-type="author"><name><surname>Orhan</surname><given-names>Elif Kocasoy</given-names></name><xref ref-type="aff" rid="aff1-0333102410361404">1</xref></contrib><contrib contrib-type="author"><name><surname>&#x000dc;stay</surname><given-names>Didem Kanca</given-names></name><xref ref-type="aff" rid="aff2-0333102410361404">2</xref></contrib><contrib contrib-type="author"><name><surname>Lieners</surname><given-names>Camille</given-names></name><xref ref-type="aff" rid="aff3-0333102410361404">3</xref></contrib><contrib contrib-type="author"><name><surname>Baykan</surname><given-names>Bet&#x000fc;l</given-names></name><xref ref-type="aff" rid="aff1-0333102410361404">1</xref></contrib><aff id="aff1-0333102410361404"><label>1</label>Istanbul Faculty of Medicine,
                    Department of Neurology, Istanbul, Turkey.</aff><aff id="aff2-0333102410361404"><label>2</label>Vivitro Ltd, Istanbul, Turkey.</aff><aff id="aff3-0333102410361404"><label>3</label>Invitalab, Neuss, Germany.</aff></contrib-group><author-notes><corresp id="corresp1-0333102410361404">Mustafa Erta&#x0015f; MD, Professor of
                    Neurology, Department of Neurology, Anadolu Health Centre, Gebze, Kocaeli,
                    Turkey. Email: <email>mustafaertas@superonline.com</email></corresp></author-notes><pub-date pub-type="epub-ppub"><month>7</month><year>2010</year></pub-date><!--Fake  ppub date generated  by PMC from publisher pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><month>7</month><year>2010</year></pub-date><volume>30</volume><issue>7</issue><fpage>829</fpage><lpage>837</lpage><history><date date-type="received"><day>10</day><month>11</month><year>2009</year></date><date date-type="accepted"><day>3</day><month>1</month><year>2010</year></date></history><permissions><copyright-statement>&#x000a9; International Headache Society 2010. Published by
                    SAGE. All rights reserved. SAGE Publications</copyright-statement><copyright-year>2010</copyright-year><copyright-holder content-type="society">International Headache Society</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0/"><license-p>This is an open-access article distributed under the terms of the Creative
                        Commons Attribution License, which permits unrestricted use, distribution,
                        and reproduction in any medium, provided the original work is properly
                        cited.</license-p></license></permissions><abstract><p><italic>Introduction:</italic> It is well-known that specific foods trigger
                    migraine attacks in some patients. We aimed to investigate the effect of diet
                    restriction, based on IgG antibodies against food antigens on the course of
                    migraine attacks in this randomised, double blind, cross-over, headache-diary
                    based trial on 30 patients diagnosed with migraine without aura.</p><p><italic>Methods:</italic> Following a 6-week baseline, IgG antibodies against 266
                    food antigens were detected by ELISA. Then, the patients were randomised to a
                    6-week diet either excluding or including specific foods with raised IgG
                    antibodies, individually. Following a 2-week diet-free interval after the first
                    diet period, the same patients were given the opposite 6-week diet (provocation
                    diet following elimination diet or vice versa). Patients and their physicians
                    were blinded to IgG test results and the type of diet (provocation or
                    elimination). Primary parameters were number of headache days and migraine
                    attack count. Of 30 patients, 28 were female and 2 were male, aged
                    19&#x02013;52 years (mean, 35&#x02009;&#x000b1;&#x02009;10
                    years).</p><p><italic>Results:</italic> The average count of reactions with abnormally high
                    titre was 24&#x02009;&#x000b1;&#x02009;11 against 266 foods.
                    Compared to baseline, there was a statistically significant reduction in the
                    number of headache days (from 10.5&#x02009;&#x000b1;&#x02009;4.4 to
                    7.5&#x02009;&#x000b1;&#x02009;3.7;
                    <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001) and number of
                    migraine attacks (from 9.0&#x02009;&#x000b1;&#x02009;4.4 to
                    6.2&#x02009;&#x000b1;&#x02009;3.8;
                    <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001) in the
                    elimination diet period.</p><p><italic>Conclusion:</italic> This is the first randomised, cross-over study in
                    migraineurs, showing that diet restriction based on IgG antibodies is an
                    effective strategy in reducing the frequency of migraine attacks.</p></abstract><kwd-group><kwd>migraine</kwd><kwd>food</kwd><kwd>diet</kwd><kwd>IgG</kwd><kwd>trigger</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-0333102410361404"><title>Introduction</title><p>The exact pathophysiology of migraine is still unclear. Besides different genetic
                mutations, there is evidence of a profound role of meningeal inflammation in
                migraine pathogenesis (<xref ref-type="bibr" rid="bibr1-0333102410361404">1</xref>,<xref ref-type="bibr" rid="bibr2-0333102410361404">2</xref>).
                Environmental trigger factors are thought to play an important role. Many
                contributing factors may trigger the occurrence of migraine attacks and food is one
                of the most well-known (<xref ref-type="bibr" rid="bibr3-0333102410361404">3</xref>&#x02013;<xref ref-type="bibr" rid="bibr8-0333102410361404">8</xref>). These, however, as with most elements of migraine, need to be
                individualised to the patient with migraine.</p><p>Since the 1930s, hidden food allergy has been suspected to be linked to migraine.
                Several studies showed significant improvement when patients were put on an
                elimination diet (<xref ref-type="bibr" rid="bibr9-0333102410361404">9</xref>&#x02013;<xref ref-type="bibr" rid="bibr14-0333102410361404">14</xref>). IgE-specific food allergy has been shown to be related with migraine
                supported by the success of individualised diet in controlling migraine attacks
                    (<xref ref-type="bibr" rid="bibr4-0333102410361404">4</xref>,<xref ref-type="bibr" rid="bibr15-0333102410361404">15</xref>). Non-IgE antibody
                mediated mechanisms have also been proposed in food allergy (<xref ref-type="bibr" rid="bibr16-0333102410361404">16</xref>). Aljada et al. (<xref ref-type="bibr" rid="bibr17-0333102410361404">17</xref>) provided evidence for the
                pro-inflammatory effect of food intake. IgG antibodies against food antigens have
                been found to be correlated with inflammation and intima media thickness in obese
                juveniles (<xref ref-type="bibr" rid="bibr18-0333102410361404">18</xref>). Several
                studies reported significant improvement in irritable bowel syndrome (IBS) by food
                elimination based on IgG antibodies against to food antigens (<xref ref-type="bibr" rid="bibr19-0333102410361404">19</xref>&#x02013;<xref ref-type="bibr" rid="bibr22-0333102410361404">22</xref>). Rees et al. (<xref ref-type="bibr" rid="bibr23-0333102410361404">23</xref>) showed a beneficial effect of a diet
                guided by IgG antibodies to food in migraine patients. Recently, Arroyave Hernandez
                et al. (<xref ref-type="bibr" rid="bibr24-0333102410361404">24</xref>) reported
                preliminary evidence that IgG-based elimination diets successfully controlled the
                migraine without need of medication.</p><p>Some foods (such as cheese, chocolate or wine) are thought to be one of the
                well-known reasons triggering of migraine attacks according to consistent reports
                from the patients. It has been reported that diet with low-fat intake could reduce
                the headache frequency and intensity (<xref ref-type="bibr" rid="bibr25-0333102410361404">25</xref>). On the other hand, some additives
                (such as triclorogalactosucrose or aspartame) may trigger attacks in some
                migraineurs (<xref ref-type="bibr" rid="bibr4-0333102410361404">4</xref>,<xref ref-type="bibr" rid="bibr26-0333102410361404">26</xref>&#x02013;<xref ref-type="bibr" rid="bibr29-0333102410361404">29</xref>). However, it is neither
                easy nor very useful to organise routine diet according to robust protocols for many
                patients (<xref ref-type="bibr" rid="bibr3-0333102410361404">3</xref>,<xref ref-type="bibr" rid="bibr30-0333102410361404">30</xref>). All this indicates
                that there is a need for an individualised approach of the diet to relieve migraine.
                One has to distinguish between inflammation-induced migraine and migraine caused by
                food via other mechanisms such as histamine-induced vasodilatation.</p><p>IgG could be one of the markers to identify food which causes inflammation and could
                cause migraine attacks in predisposed individuals.</p><p>In this study, we aimed to test the beneficial effect of diet based on specific total
                IgG antibodies (subclasses 1&#x02013;4) against 266 food antigens in controlling
                migraine in a double-blind, randomised, controlled, cross-over clinical trial.</p></sec><sec sec-type="subjects" id="sec2-0333102410361404"><title>Subjects and methods</title><sec id="sec3-0333102410361404"><title>Experimental protocol</title><p>This study was designed as a double-blind, randomised, controlled, cross-over
                    clinical trial (<xref ref-type="bibr" rid="bibr31-0333102410361404">31</xref>).
                    After the approval of the hospital ethics committee, patients giving their
                    written informed consent were recruited from headache out-patient clinic with
                    the diagnosis of migraine without aura according to the criteria of the
                    International Classification of Headache Disorders, 2nd edition (<xref ref-type="bibr" rid="bibr32-0333102410361404">32</xref>). For inclusion in
                    the study, the patients should: (i) have had at least 4 attacks and 4 headache
                    days per month within the last months; (ii) be aged 18&#x02013;55 years;
                    (iii) be treated with acute attack medications only or with preventive
                    medications unchanged at least for 3 months; and (iv) be able to understand and
                    co-operate with the needs of the study and the diet. The patients with suspected
                    or clear-cut medication overuse, pure menstrual migraine or any other associated
                    headache disorder were excluded.</p><p>The study consisted of three main phases &#x02013; baseline phase, first diet
                    phase and second diet phase (<xref ref-type="fig" rid="fig1-0333102410361404">Figure 1</xref>). In all phases, patients were asked not to change the
                    dosages of their preventive medications if they were using any. The patients
                    visited the same headache physician (first author, blinded to antibody test
                    results and the order of the patient&#x02019;s diet phases) during the whole
                    study. At the first visit (Visit-1), the eligible patients recruited for the
                    study were evaluated and asked to complete a headache diary for 6 weeks. The
                    diary included headache attack frequency, headache days, attack duration in
                    hours, attack severity in visual analogue scale (VAS) and medication
                    information. During this 6-week baseline phase, the patients were followed in
                    their usual daily diet. At the second visit (Visit-2) at the end of this 6-week
                    baseline phase, the patients returned their diaries for evaluation and gave
                    venous blood samples for detection of IgG antibodies against 266 food antigens
                    (see Appendix 1) as described below. Then, the patients were allocated to one of
                    the two 6-week diets based on a randomisation schedule either excluding
                    (elimination diet) or including (provocation diet) specific foods with
                    abnormally raised IgG antibodies, as described below. They were also asked to
                    fill in a headache diary for 6 weeks. In this &#x02018;first diet
                    phase&#x02019;, half of the patients were randomised to elimination diet and
                    other half maintained provocation diet for 6 weeks. Neither the patients nor the
                    headache physician knew if the diet was for elimination or provocation as well
                    as IgG antibody test results. At the third visit (Visit-3) at the end of the
                    &#x02018;first diet phase&#x02019;, the patients returned their diaries
                    for evaluation. Then, the patients were allowed to return to their usual diets
                    for 2 weeks without keeping diary. In &#x02018;second diet
                    phase&#x02019; following this 2-week diet-free interval, the patients who
                    were on elimination diet in the &#x02018;first diet phase&#x02019; were
                    given provocation diet for 6 weeks and vice versa. They were asked to fill a
                    headache diary for 6 weeks during the second diet phase. At the fourth visit
                    (Visit-4) following the &#x02018;second diet phase&#x02019;, diaries
                    were recollected and the diet codes were broken. Patients were informed about
                    their results and the order of the types of their diets. <fig id="fig1-0333102410361404" position="float"><label>Figure 1.</label><caption><p>Cross-over design of the study.</p></caption><graphic xlink:href="10.1177_0333102410361404-fig1"/></fig></p></sec><sec id="sec4-0333102410361404"><title>IgG antibody detection against food antigens</title><p>IgG antibodies against 266 food antigens were detected using a commercially
                    available enzyme linked immunosorbant assay (ELISA) test (ImuPro 300 test;
                    Evomed/R-Biopharm AG, Darmstadt, Germany), previously used by Wilders-Truschnig
                    et al. (<xref ref-type="bibr" rid="bibr18-0333102410361404">18</xref>) IgG
                    calibration was performed against the international reference material 1st WHO
                    IRP 67/86 for human IgG. Quantitative measurements are reported in mg/l.
                    Detection limit was 2.5&#x02009;g/l, normalised cut-off value was
                    7.5&#x02009;mg/l, according to the validation protocol provided by the
                    manufacturer. All values above 7.5&#x02009;mg/l were considered as positive
                    reaction to the corresponding food. Positive reaction was graded as:
                    &#x02018;low&#x02019; for titres between
                    7.50&#x02013;12.50&#x02009;mg/l; &#x02018;moderate&#x02019; for
                    12.51&#x02013;20&#x02009;mg/l; &#x02018;high&#x02019; for
                    20.1&#x02013;50&#x02009;mg/l; and &#x02018;very high&#x02019;
                    for 50.1&#x02013;200&#x02009;mg/l. Since IgG antibodies against food
                    disappear within 3 months to 2 years depending upon initial titre, antibody
                    detection was not repeated after the diet phases which were not long enough to
                    see any change in antibody titres.</p></sec><sec id="sec5-0333102410361404"><title>Diet preparation</title><p>Diets were arranged according to the IgG antibody results; eating habits for
                    individual patients were taken into account and patients were educated about
                    keeping diet by a dietician (DKU, co-author). Diets were assembled by this
                    dietician, trying to offer a nutritionally balanced diet. The elimination diet
                    consisted of a defined panel of IgG-negative food, while the provocation diet
                    consisted in a panel of IgG-positive food and IgG-negative food necessary to
                    comply with a balanced diet. Both elimination diet and provocation diet did not
                    differ in calorie content. Patients were not allowed to eat any other food as
                    specified by the dietician. In both diet phases, patients were never forced to
                    eat or avoid from certain foods to protect the blindness of patients and their
                    physician for the type of diet phase (elimination or provocation). Instead, they
                    were asked to follow their specially arranged diet list exactly and not to
                    consume any other food in any diet phase.</p></sec><sec id="sec6-0333102410361404"><title>Statistical analysis</title><p>The primary parameters used for comparisons were number of headache days,
                    migraine attack count, mean attack duration, median attack severity (in VAS
                    score from 0&#x02013;10), number of migraine attacks with acute medication
                    and total medication intake within 6-week periods of each three phases.
                    Statistical analyses included parametric tests to compare means (paired and
                    unpaired two sample <italic>t</italic>-test), non-parametric tests to compare
                    medians (Wilcoxon test and Mann&#x02013;Whitney test) and
                    2&#x02009;&#x000d7;&#x02009;2 chi-square test. For comparisons
                    between baseline phase and provocation phase or between baseline phase and
                    elimination phase or between provocation phase and elimination phase, both
                    paired <italic>t</italic>-tests (parametric test and Wilcoxon signed test as
                    non-parametric test) were used. For comparisons between patients whose first
                    diet phase was elimination diet and patients whose second diet phase was
                    elimination diet (to test the &#x02018;period effect&#x02019;), both
                    unpaired <italic>t</italic>-tests (parametric test and Mann&#x02013;Whitney
                    unpaired test as a non-parametric test) were used.</p></sec></sec><sec sec-type="results" id="sec7-0333102410361404"><title>Results</title><p>A total of 35 patients were recruited for the study. In the baseline phase and the
                first diet phase, five patients withdrew from the study for different reasons, such
                as moving to another city, unwillingness to maintain diet or skipping the visit. The
                remaining 30 patients fully completed the study. Of these 30 patients, 28 were
                females and 2 were males. Ages varied from 19 years to 52 years (mean,
                35&#x02009;&#x000b1;&#x02009;10 years). Their mean migraine duration was
                13&#x02009;&#x000b1;&#x02009;9 years (range, 1&#x02013;30 years).
                All 30 patients were using acute attack medication for migraine attacks and 15 were
                also using preventive medication. From the IgG antibody tests against to 266 food
                allergens, mean reaction (abnormally high titre) count was
                24&#x02009;&#x000b1;&#x02009;11 (7&#x02013;47 reactions in
                individual patients). Of the total 732 reactions, 297 (40%) were low,
                337 (46%) were moderate, 70 (10%) were high and 28
                (4%) were very high graded. The food categories are listed in <xref ref-type="table" rid="table1-0333102410361404">Table 1</xref> from the most
                frequent IgG positivity to least. <table-wrap id="table1-0333102410361404" position="float"><label>Table 1.</label><caption><p>The food categories from most frequent IgG positivity to least</p></caption><table frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1">Number of patients with positive test result
                                    (<italic>n</italic>&#x02009;=&#x02009;30)</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">Spices</td><td rowspan="1" colspan="1">27</td></tr><tr><td rowspan="1" colspan="1">Seeds and nuts</td><td rowspan="1" colspan="1">24</td></tr><tr><td rowspan="1" colspan="1">Seafood</td><td rowspan="1" colspan="1">24</td></tr><tr><td rowspan="1" colspan="1">Starch</td><td rowspan="1" colspan="1">22</td></tr><tr><td rowspan="1" colspan="1">Food additives</td><td rowspan="1" colspan="1">21</td></tr><tr><td rowspan="1" colspan="1">Vegetables</td><td rowspan="1" colspan="1">21</td></tr><tr><td rowspan="1" colspan="1">Cheese</td><td rowspan="1" colspan="1">20</td></tr><tr><td rowspan="1" colspan="1">Fruits</td><td rowspan="1" colspan="1">20</td></tr><tr><td rowspan="1" colspan="1">Sugar products</td><td rowspan="1" colspan="1">20</td></tr><tr><td rowspan="1" colspan="1">Other additives</td><td rowspan="1" colspan="1">14</td></tr><tr><td rowspan="1" colspan="1">Eggs</td><td rowspan="1" colspan="1">14</td></tr><tr><td rowspan="1" colspan="1">Milk and milk products</td><td rowspan="1" colspan="1">14</td></tr><tr><td rowspan="1" colspan="1">Infusions</td><td rowspan="1" colspan="1">13</td></tr><tr><td rowspan="1" colspan="1">Salads</td><td rowspan="1" colspan="1">10</td></tr><tr><td rowspan="1" colspan="1">Mushrooms</td><td rowspan="1" colspan="1">9</td></tr><tr><td rowspan="1" colspan="1">Yeast</td><td rowspan="1" colspan="1">5</td></tr><tr><td rowspan="1" colspan="1">Meat</td><td rowspan="1" colspan="1">5</td></tr></tbody></table></table-wrap></p><p>The parameters of headache and medication are shown in <xref ref-type="table" rid="table2-0333102410361404">Tables 2</xref> and <xref ref-type="table" rid="table3-0333102410361404">3</xref>. In the elimination diet period compared
                to both baseline period and provocation diet period, there was a statistically
                significant reduction in attack count, number of headache days, number of attacks
                with acute medication and total medication intake whilst no significant change
                occurred between the provocation diet period and the baseline period (<xref ref-type="table" rid="table2-0333102410361404">Table 2</xref>). However, attack
                severity and attack duration did not change significantly between all three phases
                    (<xref ref-type="table" rid="table2-0333102410361404">Table 2</xref>). By
                comparing percentage differences from baseline, in the elimination diet period,
                attack count, number of headache days, number of attacks with acute medication and
                total medication intake showed significant reduction compared to the provocation
                diet period (<xref ref-type="table" rid="table3-0333102410361404">Table 3</xref>).
                To test the effect of order of diet, patients were divided to two subgroups: 15
                patients with elimination diet in the &#x02018;first diet phase&#x02019; and
                15 patients with elimination diet in the &#x02018;second diet
                phase&#x02019;. We calculated the differences (in both real numbers and
                percentage differences) between the elimination diet period and the baseline,
                provocation diet period and baseline and elimination diet period and provocation
                diet period for attack count, number of headache days, number of attack with acute
                medication, total medication intake, median attack severity and mean attack duration
                for each subgroup. In none of these parameters, did the two subgroups show any
                significant difference in any of these comparisons, indicating that, whether the
                elimination diet was in the first diet phase or second diet phase, the order of
                elimination diet period had no significant effect on the outcome (<xref ref-type="table" rid="table4-0333102410361404">Table 4</xref>). Similar
                calculations were made for preventive medicine usage and there was no significant
                change in any parameters between preventive medicine users
                (<italic>n</italic>&#x02009;=&#x02009;15) and non-users
                    (<italic>n</italic>&#x02009;=&#x02009;15). <table-wrap id="table2-0333102410361404" position="float"><label>Table 2.</label><caption><p>Headache and medication parameters during study phases</p></caption><table frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1"/><th colspan="3" rowspan="1">Phases, each of 6
                                    weeks&#x02009;&#x000b1;&#x02009;SD (95%
                                    CI lower; upper limits)<hr/></th></tr><tr><th rowspan="1" colspan="1">Parameters</th><th rowspan="1" colspan="1">Baseline</th><th rowspan="1" colspan="1">Provocation diet</th><th rowspan="1" colspan="1">Elimination diet</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">Attack count</td><td rowspan="1" colspan="1">8.97&#x02009;&#x000b1;&#x02009;4.4 (7.32; 10.61)</td><td rowspan="1" colspan="1">8.13&#x02009;&#x000b1;&#x02009;4.6 (6.43; 9.83)</td><td rowspan="1" colspan="1"><xref ref-type="table-fn" rid="table-fn1-0333102410361404">*</xref>6.17&#x02009;&#x000b1;&#x02009;3.8
                                    (4.67; 7.58)</td></tr><tr><td rowspan="1" colspan="1">Number of headache days</td><td rowspan="1" colspan="1">10.53&#x02009;&#x000b1;&#x02009;4.4 (8.90; 12.17)</td><td rowspan="1" colspan="1">10.20&#x02009;&#x000b1;&#x02009;5.5 (8.15; 12.25)</td><td rowspan="1" colspan="1"><xref ref-type="table-fn" rid="table-fn1-0333102410361404">*</xref>7.47&#x02009;&#x000b1;&#x02009;3.7
                                    (6.08; 8.85)</td></tr><tr><td rowspan="1" colspan="1">Number of attacks with acute medication</td><td rowspan="1" colspan="1">6.73&#x02009;&#x000b1;&#x02009;2.9 (5.65; 7.81)</td><td rowspan="1" colspan="1">6.53&#x02009;&#x000b1;&#x02009;4.0 (5.05; 8.01)</td><td rowspan="1" colspan="1"><sup><xref ref-type="table-fn" rid="table-fn1-0333102410361404">&#x02020;</xref></sup>4.90&#x02009;&#x000b1;&#x02009;3.2 (3.69;
                                    6.11)</td></tr><tr><td rowspan="1" colspan="1">Total medication intake (tablets)</td><td rowspan="1" colspan="1">11.37&#x02009;&#x000b1;&#x02009;7.4 (8.61; 14.13)</td><td rowspan="1" colspan="1">10.57&#x02009;&#x000b1;&#x02009;7.7 (7.69; 13.44)</td><td rowspan="1" colspan="1"><sup><xref ref-type="table-fn" rid="table-fn1-0333102410361404">&#x02021;</xref></sup>7.77&#x02009;&#x000b1;&#x02009;5.7 (5.65;
                                    9.89)</td></tr><tr><td rowspan="1" colspan="1">Median attack severity (VAS)</td><td rowspan="1" colspan="1">6.02&#x02009;&#x000b1;&#x02009;1.6 (5.42; 6.62)</td><td rowspan="1" colspan="1">6.07&#x02009;&#x000b1;&#x02009;1.6 (5.47; 6.66)</td><td rowspan="1" colspan="1">6.07&#x02009;&#x000b1;&#x02009;1.6 (5.60; 6.77)</td></tr><tr><td rowspan="1" colspan="1">Mean attack duration (hours)</td><td rowspan="1" colspan="1">11.39&#x02009;&#x000b1;&#x02009;5.6 (9.30; 13.48)</td><td rowspan="1" colspan="1">12.53&#x02009;&#x000b1;&#x02009;6.7 (10.04; 15.03)</td><td rowspan="1" colspan="1">12.53&#x02009;&#x000b1;&#x02009;6.7 (9.57;
                                15.14)</td></tr></tbody></table><table-wrap-foot><fn id="table-fn1-0333102410361404"><p>*<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001/<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001;
                                    <sup>&#x02020;</sup><italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001/<italic>P</italic>&#x02009;=&#x02009;0.001;
                                    <sup>&#x02021;</sup><italic>P</italic>&#x02009;=&#x02009;0.002/<italic>P</italic>&#x02009;=&#x02009;0.001
                                in Paired <italic>t</italic>-test/Wilcoxon signed test (with
                                95% confidence intervals) comparing elimination and
                                baseline diet phases (differences are statistically
                            significant).</p></fn></table-wrap-foot></table-wrap>
                <table-wrap id="table3-0333102410361404" position="float"><label>Table 3.</label><caption><p>Percentage difference of parameters from baseline period</p></caption><table frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">Parameters</th><th rowspan="1" colspan="1">Provocation diet<xref ref-type="table-fn" rid="table-fn2-0333102410361404">*</xref>
                                    (% difference)
                                    mean&#x02009;&#x000b1;&#x02009;SD (95%
                                    CI limits<sup><xref ref-type="table-fn" rid="table-fn2-0333102410361404">&#x02020;</xref></sup>)</th><th rowspan="1" colspan="1">Elimination diet<xref ref-type="table-fn" rid="table-fn2-0333102410361404">*</xref>
                                    (% difference)
                                    mean&#x02009;&#x000b1;&#x02009;SD (95%
                                    CI limits<sup><xref ref-type="table-fn" rid="table-fn2-0333102410361404">&#x02020;</xref></sup>)</th><th rowspan="1" colspan="1"><italic>P</italic>-values<sup><xref ref-type="table-fn" rid="table-fn2-0333102410361404">&#x02021;</xref></sup> paired <italic>t</italic>-test/ Wilcoxon test</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">Attack count</td><td rowspan="1" colspan="1">&#x02212;7.81&#x02009;&#x000b1;&#x02009;37.6
                                    (&#x02212;21.85; 6.23)</td><td rowspan="1" colspan="1">&#x02212;29.11&#x02009;&#x000b1;&#x02009;26.0
                                    (&#x02212;38.83; &#x02212;19.39)</td><td rowspan="1" colspan="1"><italic>P</italic>&#x02009;=&#x02009;0.006/0.004</td></tr><tr><td rowspan="1" colspan="1">Number of headache days</td><td rowspan="1" colspan="1">&#x02212;2.77&#x02009;&#x000b1;&#x02009;35.2
                                    (&#x02212;15.93; 10.38)</td><td rowspan="1" colspan="1">&#x02212;25.68&#x02009;&#x000b1;&#x02009;30.9
                                    (&#x02212;37.22; &#x02212;14.13)</td><td rowspan="1" colspan="1"><italic>P</italic>&#x02009;=&#x02009;0.006/0.006</td></tr><tr><td rowspan="1" colspan="1">Number of attacks with acute medication</td><td rowspan="1" colspan="1">3.49&#x02009;&#x000b1;&#x02009;66.4
                                    (&#x02212;21.30; 28.29)</td><td rowspan="1" colspan="1">&#x02212;20.50&#x02009;&#x000b1;&#x02009;54.2
                                    (&#x02212;40.74; &#x02212;0.27)</td><td rowspan="1" colspan="1"><italic>P</italic>&#x02009;=&#x02009;0.006/0.002</td></tr><tr><td rowspan="1" colspan="1">Total medication intake (tablets)</td><td rowspan="1" colspan="1">7.34&#x02009;&#x000b1;&#x02009;67.0
                                    (&#x02212;17.68; 32.35)</td><td rowspan="1" colspan="1">&#x02212;16.33&#x02009;&#x000b1;&#x02009;56.6
                                    (&#x02212;37.41; 4.75)</td><td rowspan="1" colspan="1"><italic>P</italic>&#x02009;=&#x02009;0.006/0.006</td></tr><tr><td rowspan="1" colspan="1">Median attack severity (VAS)</td><td rowspan="1" colspan="1">5.12&#x02009;&#x000b1;&#x02009;33.3
                                    (&#x02212;7.33; 17.56)</td><td rowspan="1" colspan="1">8.15&#x02009;&#x000b1;&#x02009;42.0
                                    (&#x02212;7.53; 23.82)</td><td rowspan="1" colspan="1">NS
                                    (<italic>P</italic>&#x02009;=&#x02009;0.348/0.460)</td></tr><tr><td rowspan="1" colspan="1">Mean attack duration (h)</td><td rowspan="1" colspan="1">25.19&#x02009;&#x000b1;&#x02009;81.6
                                    (&#x02212;5.29; 55.67)</td><td rowspan="1" colspan="1">12.79&#x02009;&#x000b1;&#x02009;53.3
                                    (&#x02212;7.10; 32.68)</td><td rowspan="1" colspan="1">NS
                                    (<italic>P</italic>&#x02009;=&#x02009;0.442/0.738)</td></tr></tbody></table><table-wrap-foot><fn id="table-fn2-0333102410361404"><p>*Percentage difference from baseline period;
                                    <sup>&#x02020;</sup>(lower; upper) limits of 95%
                                confidence interval;
                                <sup>&#x02021;</sup><italic>P</italic>-values with
                                95% confidence interval; NS, not significant.</p></fn></table-wrap-foot></table-wrap>
                <table-wrap id="table4-0333102410361404" position="float"><label>Table 4.</label><caption><p>Percentage difference of elimination diet parameters from baseline period
                            between the groups starting with elimination diet and starting with
                            provocation diet</p></caption><table frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1"/><th colspan="2" rowspan="1">Elimination diet<hr/></th><th rowspan="1" colspan="1"/></tr><tr><th rowspan="1" colspan="1">Parameters</th><th rowspan="1" colspan="1">At 1. Diet<xref ref-type="table-fn" rid="table-fn3-0333102410361404">*</xref>
                                    (% difference<sup><xref ref-type="table-fn" rid="table-fn3-0333102410361404">&#x02020;</xref></sup>) median value (percentiles<sup><xref ref-type="table-fn" rid="table-fn3-0333102410361404">&#x02021;</xref></sup>)
                                    <italic>n</italic>&#x02009;=&#x02009;15</th><th rowspan="1" colspan="1">At 2. Diet<xref ref-type="table-fn" rid="table-fn3-0333102410361404">**</xref> (% difference)
                                    median value (percentiles)
                                    <italic>n</italic>&#x02009;=&#x02009;15</th><th rowspan="1" colspan="1"><italic>P</italic>-value (Mann&#x02013;Whitney unpaired
                                    test)</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">Attack count</td><td rowspan="1" colspan="1">&#x02212;37.5 (&#x02212;55.6; &#x02212;20.0)</td><td rowspan="1" colspan="1">&#x02212;30.0 (&#x02212;35.0; &#x02212;16.7)</td><td rowspan="1" colspan="1">NS
                                    (<italic>P</italic>&#x02009;=&#x02009;0.367)</td></tr><tr><td rowspan="1" colspan="1">Number of headache days</td><td rowspan="1" colspan="1">&#x02212;30.0 (&#x02212;50.0; 0.0)</td><td rowspan="1" colspan="1">&#x02212;33.3 (&#x02212;46.2; 0.0)</td><td rowspan="1" colspan="1">NS (<italic>P</italic>&#x02009;=0.902)</td></tr><tr><td rowspan="1" colspan="1">Number of attacks with acute medication</td><td rowspan="1" colspan="1">&#x02212;37.5 (&#x02212;55.6; 0.0)</td><td rowspan="1" colspan="1">&#x02212;30.0 (&#x02212;50.0; 0.0)</td><td rowspan="1" colspan="1">NS
                                    (<italic>P</italic>&#x02009;=&#x02009;0.653)</td></tr><tr><td rowspan="1" colspan="1">Total medication intake (tablets)</td><td rowspan="1" colspan="1">&#x02212;25.0 (&#x02212;65.2; 20.0)</td><td rowspan="1" colspan="1">&#x02212;18.2 (&#x02212;37.9; 0.0)</td><td rowspan="1" colspan="1">NS
                                    (<italic>P</italic>&#x02009;=&#x02009;0.539)</td></tr><tr><td rowspan="1" colspan="1">Median attack severity (VAS)</td><td rowspan="1" colspan="1">0.0 (0.0; 14.3)</td><td rowspan="1" colspan="1">0.0 (&#x02212;20.0; 14.3)</td><td rowspan="1" colspan="1">NS
                                    (<italic>P</italic>&#x02009;=&#x02009;0.512)</td></tr><tr><td rowspan="1" colspan="1">Mean attack duration (h)</td><td rowspan="1" colspan="1">10.9 (&#x02212;29.0; 74.9)</td><td rowspan="1" colspan="1">3.7 (&#x02212;27.3; 13.0)</td><td rowspan="1" colspan="1">NS
                                    (<italic>P</italic>&#x02009;=&#x02009;0.267)</td></tr></tbody></table><table-wrap-foot><fn id="table-fn3-0333102410361404"><p>*Patients starting with elimination diet;
                                **patients starting with provocation diet;
                                    <sup>&#x02020;</sup> percentage difference from baseline
                                period; <sup>&#x02021;</sup>(25%; 75%)
                                percentiles.</p></fn><fn id="table-fn4-0333102410361404"><p>NS, not significant in Mann-Whitney test with 95%
                                confidence interval.</p></fn></table-wrap-foot></table-wrap></p><p>We also calculated if the patient showed at least a 30% reduction and at
                least a 50% reduction for attack count and number of headache days using
                elimination diet compared to provocation diet and to the baseline period. In
                comparison between elimination and baseline phases, for parameters of the number of
                headache days and attack count, reduction was &#x02265;30% in 16
                (53%) and 16 (53%) patients, respectively, and reduction was
                &#x02265;50% in 7 (23%) and 6 (20%)
                patients, respectively. In comparison between elimination and provocation phases,
                for the number of headache days and attack count, reduction was
                &#x02265;30% in 15 (50%) and 12 (40%)
                patients, respectively, and reduction was &#x02265;50% in 6
                (20%) and 4 (13%) patients, respectively.</p></sec><sec sec-type="discussion" id="sec8-0333102410361404"><title>Discussion</title><p>The concept that food may trigger some symptoms creates an increasing pressure on the
                healthcare system to investigate possible causal relationships between food intake
                and specific diseases. In the case of migraine, it seems evident that food is not
                the primary cause but, via different mechanisms, is able to induce or aggravate
                migraine attacks. In some individuals, the consumption of chocolate or red wine is
                enough to provoke an attack; whereas, in others, a combination of food is required,
                even sometimes with food which has never been related to migraine for other
                migraineurs. However, it is neither easy nor very useful to organise routine diet
                according to robust protocols for many patients (<xref ref-type="bibr" rid="bibr3-0333102410361404">3</xref>,<xref ref-type="bibr" rid="bibr30-0333102410361404">30</xref>). All this indicates that there is a
                need for an individualised approach to diet to relieve migraine.</p><p>A recent study addressed a relationship between IgG antibodies against food antigens
                and systemic inflammation measured by C-reactive protein (CRP) in obese juvenile
                patients (<xref ref-type="bibr" rid="bibr18-0333102410361404">18</xref>). Obesity
                was also shown as an important risk factor in the development of chronic daily
                headache and chronic migraine (<xref ref-type="bibr" rid="bibr33-0333102410361404">33</xref>,<xref ref-type="bibr" rid="bibr34-0333102410361404">34</xref>). The
                therapeutic potential of dietary elimination on the basis of the presence of IgG
                antibodies against food in patients with IBS has been investigated. Patients were
                randomised to receive either a diet excluding all foods to which they had raised IgG
                antibodies or a sham diet excluding the same number of foods but not those to which
                they had antibodies (<xref ref-type="bibr" rid="bibr19-0333102410361404">19</xref>).
                The true diet resulted in a statistically significant reduction in symptom scores
                compared to the sham diet and the authors concluded that this technique is worthy of
                further clinical research in IBS.</p><p>There is growing evidence that inflammation plays an important role in the
                pathogenesis of migraine (<xref ref-type="bibr" rid="bibr2-0333102410361404">2</xref>). The calcitonin gene-related peptide (CGRP), and nitric oxide (NO) may
                participate in immune and inflammatory responses. Some patients report that certain
                foods only trigger migraine in conjunction with stress or extended physical
                exercise. Both conditions, recognised as triggers of migraine, cause the release of
                pro-inflammatory cytokines. In these cases, inflammation caused by food could create
                the pro-inflammatory milieu necessary for the induction of migraine by other
                triggers. If we focus on inflammation induced by food, a specific marker is needed.
                All IgG subclasses, except IgG4 lead to an inflammatory response when in contact
                with the respective antigen. Determination of specific IgG to a large number of
                foods is an ideal tool to detect individually suspected food and enables a
                modification of nutritional habits in order to prevent chronic inflammation and
                onset of migraine in sensitised patients. Susceptibility to other triggers such as
                histamine, caused by impaired detoxification by low activity of di-amino-oxidase,
                may play an additional role and could be considered in the proposed diet.</p><p>A recent study from Mexico investigated 56 patients with recurrent attacks of
                migraine (at least once a month) and 56 control subjects without migraine and
                measured their allergen-specific IgG against 108 food allergens by enzyme
                immunoassay (<xref ref-type="bibr" rid="bibr24-0333102410361404">24</xref>). The
                authors reported that there was a statistically significant difference in the number
                of positive results for IgG food allergens between patients and controls and the
                elimination diet successfully controls the migraine without need of medication. As
                distinct from this study, we used a randomised, cross-over design with clear
                definition of diagnostic and follow-up criteria and study set-up. We used a baseline
                period and provocative diet periods to compare elimination diet period of the same
                individuals as their own controls instead of using other healthy volunteers.</p><p>Our data confirm the importance of determination of specific IgG antibodies against
                food antigens for prevention and cure of food-induced migraine attacks, leading to
                lower drug consumption, fewer adverse drug reactions and fewer days with
            migraine.</p></sec><sec sec-type="conclusions" id="sec9-0333102410361404"><title>Conclusions</title><p>Diet restriction based on IgG antibodies might be an effective strategy in reducing
                the frequency of migraine attacks and could be implemented for therapy-resistant
                patient. However, because of the small sample size of this study, caution is
                required while translating these results into daily practice. Further research is
                also needed to determine the mechanism of IgG positive, food-induced migraine and
                its relation to other triggers.</p></sec></body><back><ack><title>Acknowledgements</title><p>Kadriye Alpay and Mustafa Erta&#x0015f; contributed equally to the study. Mustafa
                Erta&#x0015f; conducted the statistical analyses; he is a lecturer in
                biostatistics.</p></ack><ref-list><title>References</title><ref id="bibr1-0333102410361404"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Longoni</surname><given-names>M</given-names></name><name><surname>Ferrarese</surname><given-names>C</given-names></name></person-group> <article-title>Inflammation and excitotoxicity: role in
                        migraine pathogenesis</article-title>. <source>Neurol Sci</source><year>2006</year>; <volume>27</volume>(<issue>Suppl 2</issue>):
                        <fpage>S107</fpage>&#x02013;<lpage>S110</lpage><pub-id pub-id-type="pmid">16688611</pub-id></mixed-citation></ref><ref id="bibr2-0333102410361404"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geppetti</surname><given-names>P</given-names></name><name><surname>Capone</surname><given-names>JG</given-names></name><name><surname>Trevisani</surname><given-names>M</given-names></name><name><surname>Nicoletti</surname><given-names>P</given-names></name><name><surname>Zagli</surname><given-names>G</given-names></name><name><surname>Tola</surname><given-names>MR</given-names></name></person-group> <article-title>CGRP and migraine; neurogenic inflammation
                        revisited</article-title>. <source>J Headache Pain</source><year>2005</year>; <volume>6</volume>:
                    <fpage>61</fpage>&#x02013;<lpage>70</lpage><pub-id pub-id-type="pmid">16362644</pub-id></mixed-citation></ref><ref id="bibr3-0333102410361404"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diamond</surname><given-names>S</given-names></name><name><surname>Prager</surname><given-names>J</given-names></name><name><surname>Freitag</surname><given-names>FG</given-names></name></person-group> <article-title>Diet and headache Is there a
                    link?</article-title>. <source>Postgrad Med J</source><year>1986</year>; <volume>79</volume>:
                        <fpage>279</fpage>&#x02013;<lpage>286</lpage></mixed-citation></ref><ref id="bibr4-0333102410361404"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Millichap</surname><given-names>JG</given-names></name><name><surname>Yee</surname><given-names>MM</given-names></name></person-group> <article-title>The diet factor in pediatric and adolescent
                        migraine</article-title>. <source>Pediatr Neurol</source><year>2003</year>; <volume>28</volume>:
                    <fpage>9</fpage>&#x02013;<lpage>15</lpage><pub-id pub-id-type="pmid">12657413</pub-id></mixed-citation></ref><ref id="bibr5-0333102410361404"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peatfield</surname><given-names>RC</given-names></name><name><surname>Glover</surname><given-names>V</given-names></name><name><surname>Littlewood</surname><given-names>JT</given-names></name><name><surname>Sandler</surname><given-names>M</given-names></name><name><surname>Clifford Rose</surname><given-names>F</given-names></name></person-group> <article-title>The prevalence of diet-induced
                    migraine</article-title>. <source>Cephalalgia</source><year>1984</year>; <volume>4</volume>:
                    <fpage>179</fpage>&#x02013;<lpage>183</lpage><pub-id pub-id-type="pmid">6498931</pub-id></mixed-citation></ref><ref id="bibr6-0333102410361404"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peatfield</surname><given-names>RC</given-names></name></person-group> <article-title>Relationships between food, wine, and
                        beer-precipitated migrainous headaches</article-title>. <source>Headache</source><year>1995</year>; <volume>35</volume>:
                        <fpage>355</fpage>&#x02013;<lpage>357</lpage><pub-id pub-id-type="pmid">7635722</pub-id></mixed-citation></ref><ref id="bibr7-0333102410361404"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Savi</surname><given-names>L</given-names></name><name><surname>Rainero</surname><given-names>I</given-names></name><name><surname>Valfre</surname><given-names>W</given-names></name><name><surname>Gentile</surname><given-names>S</given-names></name><name><surname>Lo Giudice</surname><given-names>R</given-names></name><name><surname>Pinessi</surname><given-names>L</given-names></name></person-group> <article-title>Food and headache attacks. A comparison of
                        patients with migraine and tension-type headache</article-title>.
                        <source>Panminerva Med</source><year>2002</year>; <volume>44</volume>:
                    <fpage>27</fpage>&#x02013;<lpage>31</lpage><pub-id pub-id-type="pmid">11887088</pub-id></mixed-citation></ref><ref id="bibr8-0333102410361404"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vaughan</surname><given-names>TR</given-names></name></person-group> <article-title>The role of food in the pathogenesis of migraine
                        headache</article-title>. <source>Clin Rev Allergy</source><year>1994</year>; <volume>12</volume>:
                        <fpage>167</fpage>&#x02013;<lpage>180</lpage><pub-id pub-id-type="pmid">7954188</pub-id></mixed-citation></ref><ref id="bibr9-0333102410361404"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balyeat</surname><given-names>RM</given-names></name><name><surname>Brittain</surname><given-names>FL</given-names></name></person-group> <article-title>Allergic migraine: based on the study of
                        fifty-five cases</article-title>. <source>Am J Med Sci</source><year>1930</year>; <volume>180</volume>:
                        <fpage>212</fpage>&#x02013;<lpage>221</lpage></mixed-citation></ref><ref id="bibr10-0333102410361404"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheldon</surname><given-names>JM</given-names></name><name><surname>Randolph</surname><given-names>TG</given-names></name></person-group> <article-title>Allergy in migraine-like
                    headaches</article-title>. <source>Am J Med Sci</source><year>1935</year>; <volume>190</volume>:
                        <fpage>232</fpage>&#x02013;<lpage>236</lpage></mixed-citation></ref><ref id="bibr11-0333102410361404"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heymann</surname><given-names>H</given-names></name></person-group> <article-title>Migraine and food allergy, a survey of 20
                    cases</article-title>. <source>S Afr Med J</source><year>1952</year>; <volume>26</volume>:
                        <fpage>949</fpage>&#x02013;<lpage>950</lpage><pub-id pub-id-type="pmid">13028775</pub-id></mixed-citation></ref><ref id="bibr12-0333102410361404"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Speer</surname><given-names>F</given-names></name></person-group> <article-title>Allergy and migraine: a clinical
                    study</article-title>. <source>Headache</source><year>1971</year>; <volume>11</volume>:
                    <fpage>63</fpage>&#x02013;<lpage>67</lpage><pub-id pub-id-type="pmid">4938336</pub-id></mixed-citation></ref><ref id="bibr13-0333102410361404"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Egger</surname><given-names>J</given-names></name><name><surname>Carter</surname><given-names>CM</given-names></name><name><surname>Wilson</surname><given-names>J</given-names></name><name><surname>Turner</surname><given-names>MW</given-names></name><name><surname>Soothill</surname><given-names>JF</given-names></name></person-group> <article-title>Is migraine food allergy? A double-blind
                        controlled trial of oligoantigenic diet treatment</article-title>.
                        <source>Lancet</source><year>1983</year>; <volume>2</volume>:
                    <fpage>865</fpage>&#x02013;<lpage>869</lpage><pub-id pub-id-type="pmid">6137694</pub-id></mixed-citation></ref><ref id="bibr14-0333102410361404"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monro</surname><given-names>J</given-names></name><name><surname>Carini</surname><given-names>C</given-names></name><name><surname>Brostoff</surname><given-names>J</given-names></name></person-group> <article-title>Migraine is a food-allergic
                    disease</article-title>. <source>Lancet</source><year>1984</year>; <volume>2</volume>:
                    <fpage>719</fpage>&#x02013;<lpage>721</lpage><pub-id pub-id-type="pmid">6148473</pub-id></mixed-citation></ref><ref id="bibr15-0333102410361404"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mansfield</surname><given-names>LE</given-names></name><name><surname>Vaughan</surname><given-names>TR</given-names></name><name><surname>Waller</surname><given-names>SF</given-names></name><name><surname>Haverly</surname><given-names>RW</given-names></name><name><surname>Ting</surname><given-names>S</given-names></name></person-group> <article-title>Food allergy and adult migraine: double-blind
                        and mediator confirmation of an allergic etiology</article-title>.
                        <source>Ann Allergy</source><year>1985</year>; <volume>55</volume>:
                        <fpage>126</fpage>&#x02013;<lpage>129</lpage><pub-id pub-id-type="pmid">4025956</pub-id></mixed-citation></ref><ref id="bibr16-0333102410361404"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halpern</surname><given-names>GM</given-names></name><name><surname>Scott</surname><given-names>JR</given-names></name></person-group> <article-title>Non-IgE antibody mediated mechanisms in food
                        allergy</article-title>. <source>Ann Allergy</source><year>1987</year>; <volume>58</volume>:
                    <fpage>14</fpage>&#x02013;<lpage>27</lpage><pub-id pub-id-type="pmid">3099610</pub-id></mixed-citation></ref><ref id="bibr17-0333102410361404"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aljada</surname><given-names>A</given-names></name><name><surname>Mohanty</surname><given-names>P</given-names></name><name><surname>Ghanim</surname><given-names>H</given-names></name><etal/></person-group> <article-title>Increase in intranuclear nuclear factor kappaB
                        and decrease in inhibitor kappaB in mononuclear cells after a mixed meal:
                        evidence for a proinflammatory effect</article-title>. <source>Am J Clin
                        Nutr</source><year>2004</year>; <volume>79</volume>:
                        <fpage>682</fpage>&#x02013;<lpage>690</lpage><pub-id pub-id-type="pmid">15051615</pub-id></mixed-citation></ref><ref id="bibr18-0333102410361404"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilders-Truschnig</surname><given-names>M</given-names></name><name><surname>Mangge</surname><given-names>H</given-names></name><name><surname>Lieners</surname><given-names>C</given-names></name><name><surname>Gruber</surname><given-names>H</given-names></name><name><surname>Mayer</surname><given-names>C</given-names></name><name><surname>Marz</surname><given-names>W</given-names></name></person-group> <article-title>IgG antibodies against food antigens are
                        correlated with inflammation and intima media thickness in obese
                    juveniles</article-title>. <source>Exp Clin Endocrinol Diabetes</source><year>2008</year>; <volume>116</volume>:
                        <fpage>241</fpage>&#x02013;<lpage>245</lpage><pub-id pub-id-type="pmid">18072008</pub-id></mixed-citation></ref><ref id="bibr19-0333102410361404"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atkinson</surname><given-names>W</given-names></name><name><surname>Sheldon</surname><given-names>TA</given-names></name><name><surname>Shaath</surname><given-names>N</given-names></name><name><surname>Whorwell</surname><given-names>PJ</given-names></name></person-group> <article-title>Food elimination based on IgG antibodies in
                        irritable bowel syndrome: a randomised controlled trial</article-title>.
                        <source>Gut</source><year>2004</year>; <volume>53</volume>:
                        <fpage>1459</fpage>&#x02013;<lpage>1464</lpage><pub-id pub-id-type="pmid">15361495</pub-id></mixed-citation></ref><ref id="bibr20-0333102410361404"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zar</surname><given-names>S</given-names></name><name><surname>Mincher</surname><given-names>L</given-names></name><name><surname>Benson</surname><given-names>MJ</given-names></name><name><surname>Kumar</surname><given-names>D</given-names></name></person-group> <article-title>Food-specific IgG4 antibody-guided exclusion
                        diet improves symptoms and rectal compliance in irritable bowel
                    syndrome</article-title>. <source>Scand J Gastroenterol</source><year>2005</year>; <volume>40</volume>:
                        <fpage>800</fpage>&#x02013;<lpage>807</lpage><pub-id pub-id-type="pmid">16109655</pub-id></mixed-citation></ref><ref id="bibr21-0333102410361404"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drisko</surname><given-names>J</given-names></name><name><surname>Bischoff</surname><given-names>B</given-names></name><name><surname>Hall</surname><given-names>M</given-names></name><name><surname>McCallum</surname><given-names>R</given-names></name></person-group> <article-title>Treating irritable bowel syndrome with a food
                        elimination diet followed by food challenge and probiotics</article-title>.
                        <source>J Am Coll Nutr</source><year>2006</year>; <volume>25</volume>:
                        <fpage>514</fpage>&#x02013;<lpage>522</lpage><pub-id pub-id-type="pmid">17229899</pub-id></mixed-citation></ref><ref id="bibr22-0333102410361404"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zuo</surname><given-names>XL</given-names></name><name><surname>Li</surname><given-names>YQ</given-names></name><name><surname>Li</surname><given-names>WJ</given-names></name><etal/></person-group> <article-title>Alterations of food antigen-specific serum
                        immunoglobulins G and E antibodies in patients with irritable bowel syndrome
                        and functional dyspepsia</article-title>. <source>Clin Exp Allergy</source><year>2007</year>; <volume>37</volume>:
                        <fpage>823</fpage>&#x02013;<lpage>830</lpage><pub-id pub-id-type="pmid">17517095</pub-id></mixed-citation></ref><ref id="bibr23-0333102410361404"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rees</surname><given-names>T</given-names></name><name><surname>Watson</surname><given-names>D</given-names></name></person-group> <article-title>A prospective audit of food intolerance among
                        migraine patients in primary care clinical practice</article-title>.
                        <source>Headache Care</source><year>2005</year>; <volume>2</volume>:
                    <fpage>11</fpage>&#x02013;<lpage>14</lpage></mixed-citation></ref><ref id="bibr24-0333102410361404"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arroyave Hernandez</surname><given-names>CM</given-names></name><name><surname>Echevarria Pinto</surname><given-names>M</given-names></name><name><surname>Hernandez Montiel</surname><given-names>HL</given-names></name></person-group> <article-title>Food allergy mediated by IgG antibodies
                        associated with migraine in adults</article-title>. <source>Rev Alerg Mex</source><year>2007</year>; <volume>54</volume>:
                        <fpage>162</fpage>&#x02013;<lpage>168</lpage><pub-id pub-id-type="pmid">18693538</pub-id></mixed-citation></ref><ref id="bibr25-0333102410361404"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bic</surname><given-names>Z</given-names></name><name><surname>Blix</surname><given-names>GG</given-names></name><name><surname>Hopp</surname><given-names>HP</given-names></name><name><surname>Leslie</surname><given-names>FM</given-names></name><name><surname>Schell</surname><given-names>MJ</given-names></name></person-group> <article-title>The influence of a low-fat diet on incidence and
                        severity of migraine headaches</article-title>. <source>J Womens Health Gend
                        Based Med</source><year>1999</year>; <volume>8</volume>:
                    <fpage>623</fpage>&#x02013;<lpage>630</lpage><pub-id pub-id-type="pmid">10839648</pub-id></mixed-citation></ref><ref id="bibr26-0333102410361404"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bigal</surname><given-names>ME</given-names></name><name><surname>Krymchantowski</surname><given-names>AV</given-names></name></person-group> <article-title>Migraine triggered by sucralose &#x02013; a
                        case report</article-title>. <source>Headache</source><year>2006</year>; <volume>46</volume>:
                        <fpage>515</fpage>&#x02013;<lpage>517</lpage><pub-id pub-id-type="pmid">16618274</pub-id></mixed-citation></ref><ref id="bibr27-0333102410361404"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>RM</given-names></name><name><surname>Sarma</surname><given-names>R</given-names></name><name><surname>Grimsley</surname><given-names>E</given-names></name></person-group> <article-title>Popular sweetner sucralose as a migraine
                    trigger</article-title>. <source>Headache</source><year>2006</year>; <volume>46</volume>:
                        <fpage>1303</fpage>&#x02013;<lpage>1304</lpage><pub-id pub-id-type="pmid">16942478</pub-id></mixed-citation></ref><ref id="bibr28-0333102410361404"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newman</surname><given-names>LC</given-names></name><name><surname>Lipton</surname><given-names>RB</given-names></name></person-group> <article-title>Migraine MLT-down: an unusual presentation of
                        migraine in patients with aspartame-triggered headaches</article-title>.
                        <source>Headache</source><year>2001</year>; <volume>41</volume>:
                        <fpage>899</fpage>&#x02013;<lpage>901</lpage><pub-id pub-id-type="pmid">11703479</pub-id></mixed-citation></ref><ref id="bibr29-0333102410361404"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van den Eeden</surname><given-names>SK</given-names></name><name><surname>Koepsell</surname><given-names>TD</given-names></name><name><surname>Longstreth Jr</surname><given-names>WT</given-names></name><name><surname>van Belle</surname><given-names>G</given-names></name><name><surname>Daling</surname><given-names>JR</given-names></name><name><surname>McKnight</surname><given-names>B</given-names></name></person-group> <article-title>Aspartame ingestion and headaches: a randomized
                        crossover trial</article-title>. <source>Neurology</source><year>1994</year>; <volume>44</volume>:
                        <fpage>1787</fpage>&#x02013;<lpage>1793</lpage><pub-id pub-id-type="pmid">7936222</pub-id></mixed-citation></ref><ref id="bibr30-0333102410361404"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blau</surname><given-names>JN</given-names></name></person-group> <article-title>Migraine triggers: practice and
                    theory</article-title>. <source>Pathol Biol (Paris)</source><year>1992</year>; <volume>40</volume>:
                        <fpage>367</fpage>&#x02013;<lpage>372</lpage><pub-id pub-id-type="pmid">1495822</pub-id></mixed-citation></ref><ref id="bibr31-0333102410361404"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tfelt-Hansen</surname><given-names>P</given-names></name><name><surname>Block</surname><given-names>G</given-names></name><name><surname>Dahlof</surname><given-names>C</given-names></name><etal/></person-group> <article-title>Guidelines for controlled trials of drugs in
                        migraine, 2nd edition</article-title>. <source>Cephalalgia</source><year>2000</year>; <volume>20</volume>:
                        <fpage>765</fpage>&#x02013;<lpage>786</lpage><pub-id pub-id-type="pmid">11167908</pub-id></mixed-citation></ref><ref id="bibr32-0333102410361404"><label>32.</label><mixed-citation publication-type="journal"><collab>Headache Classification Subcommittee of
                        the International Headache Society</collab><article-title>The International
                        Classification of Headache Disorders, 2nd edition</article-title>.
                        <source>Cephalalgia</source><year>2004</year>; <volume>24</volume>(<issue>Suppl 1</issue>):
                        <fpage>9</fpage>&#x02013;<lpage>160</lpage><pub-id pub-id-type="pmid">14979299</pub-id></mixed-citation></ref><ref id="bibr33-0333102410361404"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bigal</surname><given-names>ME</given-names></name><name><surname>Lipton</surname><given-names>RB</given-names></name><name><surname>Holland</surname><given-names>PR</given-names></name><name><surname>Goadsby</surname><given-names>PJ</given-names></name></person-group> <article-title>Obesity, migraine, and chronic migraine:
                        possible mechanisms of interaction</article-title>. <source>Neurology</source><year>2007</year>; <volume>68</volume>:
                        <fpage>1851</fpage>&#x02013;<lpage>1861</lpage><pub-id pub-id-type="pmid">17515549</pub-id></mixed-citation></ref><ref id="bibr34-0333102410361404"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bigal</surname><given-names>ME</given-names></name><name><surname>Liberman</surname><given-names>JN</given-names></name><name><surname>Lipton</surname><given-names>RB</given-names></name></person-group> <article-title>Obesity and migraine: a population
                    study</article-title>. <source>Neurology</source><year>2006</year>; <volume>66</volume>:
                        <fpage>545</fpage>&#x02013;<lpage>550</lpage><pub-id pub-id-type="pmid">16354886</pub-id></mixed-citation></ref></ref-list><app-group><title>Appendix 1</title><app id="app1-0333102410361404"><title>Full list of 266 food allergens tested</title><list list-type="simple"><title>Milk</title><list-item><p>Milk (cow)</p><p>Goat: milk and cheese</p></list-item></list><list list-type="simple"><title>Milk products</title><list-item><p>Buttermilk</p><p>Cottage cheese</p><p>Yogurt</p><p>Whey</p><p>Curd cheese</p><p>Camembert</p><p>Edam cheese</p><p>Emmenthal cheese</p><p>Gouda cheese</p><p>Leerdamer cheese</p><p>Mozzarella</p><p>Parmesan</p><p>Ricotta</p><p>Roquefort</p><p>Processed cheese</p><p>Tilsit cheese</p><p>Sheep cheese</p></list-item></list><list list-type="simple"><title>Food additives</title><list-item><p>Benzoic acid (E211)</p><p>Citric acid (E330)</p><p>Sorbic acid (E200)</p><p>Agar-Agar (E406)</p><p>Carrageen (E407)</p><p>Gelatine</p><p>Guar flour (E412)</p><p>Pectin (E440)</p><p>Traganth (E413)</p><p>Amarant (E123)</p><p>Azorubin (E122)</p><p>Quinoline yellow (E104)</p><p>Cochinella (E120)</p><p>Erytrosin (E127)</p><p>Yellow Orange FCF (E110)</p><p>Curcumin (E100)</p><p>Tartrazine (E102)</p><p>Glutamate (E621)</p><p>
                            <italic>Aspergillus niger</italic>
                        </p><p>Starch</p><p>Spelt</p><p>Barley</p><p>Gluten</p><p>Unripe spelt grain</p><p>Oat</p><p>Kamut</p><p>Rye</p><p>Wheat</p><p>Amaranth</p><p>Broad bean</p><p>Buckwheat</p><p>Millet</p><p>Potato</p><p>Chickpeas</p><p>Lentil</p><p>Maize, sweet corn</p><p>Quinoa</p><p>Rice</p><p>Soy bean</p><p>Tapioca, cassava</p></list-item></list><list list-type="simple"><title>Infusions</title><list-item><p>Valerian</p><p>Nettle</p><p>Tea, green</p><p>Rose hip</p><p>Hibiscus leaves</p><p>Coffee</p><p>Chamomile</p><p>Lime blossoms</p><p>Rooibus tea</p><p>Tea, black</p><p>Hawthorn</p></list-item></list><list list-type="simple"><title>Other additives</title><list-item><p>Aloe Vera</p><p>Rape-seed oil</p><p>Tannin</p><p>Eggs</p><p>Yellow chicken egg</p><p>Chicken egg white</p></list-item></list><list list-type="simple"><title>Sugar products</title><list-item><p>Agave nectar</p><p>Maple syrup</p><p>Aspartame (E951)</p><p>Carob</p><p>Honey</p><p>Coconut</p><p>Malt</p><p>Cane sugar</p></list-item></list><list list-type="simple"><title>Spices</title><list-item><p>Aniseed</p><p>Basil</p><p>Savory</p><p>Cayenne pepper</p><p>Chili</p><p>Candied lemon peel</p><p>Curry powder</p><p>Dill</p><p>Vervain</p><p>Hop</p><p>Ginger</p><p>Cardamom</p><p>Chervil</p><p>Garlic</p><p>Coriander</p><p>Caraway</p><p>Lavender</p><p>Lovage</p><p>Bay leaf</p><p>Marjoram</p><p>Horseradish</p><p>Nutmeg</p><p>Clove</p><p>Oregano</p><p>Paprika</p><p>Parsley</p><p>Parsley root</p><p>Peppermint</p><p>Allspice</p><p>Rosemary</p><p>Saffron</p><p>Sage</p><p>Chive</p><p>Pepper, black</p><p>Mustard seed</p><p>Thyme</p><p>Vanilla</p><p>Juniper berry</p><p>Pepper, white</p><p>Cinnamon</p><p>Lemon balm</p></list-item></list><list list-type="simple"><title>Meat</title><list-item><p>Veal</p><p>Lamb</p><p>Beef</p><p>Pork</p><p>Duck</p><p>Goose</p><p>Chicken</p><p>Ostrich meat</p><p>Turkey hen</p><p>Quail</p><p>Rabbit</p><p>Deer</p><p>Hare</p><p>Roe deer</p><p>Wild boar</p></list-item></list><list list-type="simple"><title>Seafood</title><list-item><p>Eel</p><p>Anchovy</p><p>Trout</p><p>Shark</p><p>Sole</p><p>Herring</p><p>Cod, codling</p><p>Carp</p><p>Salmon</p><p>Mackerel</p><p>Ocean perch</p><p>Sardine</p><p>Haddock</p><p>Plaice</p><p>Swordfish</p><p>Tuna fish</p><p>Zander</p><p>Oysters</p><p>Blue mussels</p><p>Squid</p><p>Shrimp, prawn</p><p>Lobster</p><p>Crayfish</p></list-item></list><list list-type="simple"><title>Fruits</title><list-item><p>Pineapple</p><p>Apple</p><p>Apricot</p><p>Banana</p><p>Pear</p><p>Blueberry</p><p>Blackberry</p><p>Strawberry</p><p>Fig</p><p>Raspberry</p><p>Honeydew melon</p><p>Cherry</p><p>Kiwi</p><p>Lychee</p><p>Mandarin</p><p>Mango</p><p>Yellow plum</p><p>Nectarine</p><p>Orange</p><p>Grapefruit</p><p>Papaya</p><p>Peach</p><p>Plum</p><p>Cranberry</p><p>Quince</p><p>Sea buckthorn</p><p>Currant</p><p>Gooseberry</p><p>Grape</p><p>Watermelon</p><p>Lemon</p><p>Sugar melon</p><p>Chestnut</p><p>Date</p><p>Raisins</p><p>Avocado</p><p>Olive</p></list-item></list><list list-type="simple"><title>Seeds and nuts</title><list-item><p>Cashew kernels</p><p>Peanut</p><p>Hazelnut</p><p>Coconut</p><p>Pumpkin seeds</p><p>Linseed</p><p>Almond</p><p>Poppy seeds</p><p>Brazil nut</p><p>Pine nut</p><p>Pistachio</p><p>Sesame</p><p>Sunflower seed</p><p>Walnut</p></list-item></list><list list-type="simple"><title>Vegetables</title><list-item><p>Artichoke</p><p>Aubergine</p><p>Bamboo shoots</p><p>Cauliflower</p><p>Beans, yellow</p><p>Green bean</p><p>Broccoli</p><p>Chinese cabbage</p><p>Green pea</p><p>Fennel</p><p>Savoy cabbage</p><p>Cucumber</p><p>Carrots</p><p>Rutabaga</p><p>Pumpkin</p><p>Leek</p><p>Chard, beet greens</p><p>Green gram</p><p>Sweet pepper</p><p>Radish red</p><p>Radish black</p><p>Rhubarb</p><p>Brussels sprouts</p><p>Beetroot</p><p>Red cabbage</p><p>Shallot</p><p>Black salsify</p><p>Celeriac, knob celery</p><p>Asparagus</p><p>Spinach</p><p>Tomato</p><p>White cabbage</p><p>Kale, curled kale</p><p>Courgette</p><p>Onion</p><p>Salads</p><p>Watercress</p><p>Chicory</p><p>Iceberg lettuce</p><p>Endive</p><p>Butterhead lettuce</p><p>Head lettuce</p><p>Dandelion</p><p>Radicchio</p><p>Romaine/Cos lettuce</p><p>Rocket</p></list-item></list><list list-type="simple"><title>Mushrooms</title><list-item><p>Oyster mushrooms</p><p>Meadow mushrooms</p><p>Bay boletus</p><p>Chanterelle</p><p>Shiitake</p><p>Cep (boletus)</p></list-item></list><list list-type="simple"><title>Yeast</title><list-item><p>Yeast</p><p>Baking powder</p></list-item></list></app></app-group></back></article>